KOMAL PATEL: Open Payments
NPI 1154666238 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 70 payments from 25 companies in 2025. Trend: 2023 $1,300 · 2024 $1,603 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $271 |
| Abbott Laboratories | 15 | $234 |
| Ascendis Pharma Endocrinology Inc | 5 | $110 |
| Radius Health, Inc. | 3 | $80 |
| Mannkind Corporation | 3 | $75 |
| KYOWA KIRIN, INC. | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Amgen Inc. | 3 | $50 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $46 |
| Corcept Therapeutics | 2 | $45 |
Products named: FREESTYLE LIBRE 3, Yorvipath, Wegovy, Ozempic, AFREZZA, CRYSVITA, Kerendia, Rybelsus.
Industry payments across NC — which companies pay providers there.
